Open Orphan (LON:ORPH) Trading 5.3% Higher

Open Orphan Plc (LON:ORPHGet Free Report) traded up 5.3% during trading on Wednesday . The stock traded as high as GBX 10.38 ($0.13) and last traded at GBX 10 ($0.13). 652,639 shares were traded during mid-day trading, a decline of 58% from the average session volume of 1,559,247 shares. The stock had previously closed at GBX 9.50 ($0.12).

Open Orphan Trading Up 5.3 %

The company has a current ratio of 1.19, a quick ratio of 1.16 and a debt-to-equity ratio of 10.88. The stock has a market capitalization of £67.09 million and a P/E ratio of -25.30. The business’s fifty day simple moving average is GBX 10 and its two-hundred day simple moving average is GBX 10.

Open Orphan Company Profile

(Get Free Report)

Open Orphan Plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.

See Also

Receive News & Ratings for Open Orphan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Open Orphan and related companies with MarketBeat.com's FREE daily email newsletter.